Infectious Disease Diagnostic Testing: World Market Analysis, 2024-2029

As infectious diseases continue to pose significant global health challenges, diagnostic testing has emerged as a vital tool in detecting and managing these threats. Today, infectious disease testing stands at the forefront of the rapidly expanding in vitro diagnostics (IVD) industry, representing one of its largest and most dynamic segments.

This comprehensive market research report from Kalorama Information delves into the world of infectious disease IVD, presenting unparalleled insights and forecasts for 2024-2029. Designed for industry professionals, investors, and market strategists, this report will equip you with the knowledge needed to stay ahead in a competitive and rapidly evolving sector.

Report Features:

  • Comprehensive Market Coverage: Understand the dynamic landscape of infectious disease diagnostics, spanning key test categories such as:
    • Healthcare-Associated Infections (HAIs)
    • COVID-19 
    • Hepatitis 
    • STIs
    • Influenza 
    • HIV/AIDS 
    • Tuberculosis 
    • TORCH
    • Other infectious diseases (including Dengue Fever, Emerging Infections, Fungal, Lyme Disease, Malaria, Other Parasitic, RSV, Streptococcal)
  • Global Reach with Local Insights: Gain valuable perspectives on opportunities in diverse geographic regions, including North America, Western Europe, Asia/Pacific, and emerging markets across Central & South America, Africa, and the Middle East.
  • Strategic Market Drivers: Explore the macroeconomic and healthcare trends driving the need for advanced diagnostics and how aging populations and globalized threats are influencing market growth.
  • Competitive Intelligence: Analyze the leading players and their IVD innovations, helping you benchmark against industry leaders and identify potential partnerships or competitive advantages.

Scope and Methodology You Can Trust: Backed by Kalorama Information’s extensive experience and robust analytical frameworks, this report synthesizes data from public records, epidemiological research, key competitor analysis, and economic modeling. Our insights are further enriched by expert interviews and proprietary databases, ensuring you get actionable, reliable forecasts.

 

Table of Contents
  • Chapter 1: Executive Summary
    • A Mix of Traditional and Emerging Testing Technologies
    • Market Drivers
    • The World Infectious Disease Testing Market
    • Major Findings of the Report
    • Scope and Methodology
  • Chapter 2: Market Environment
    • Overview
    • Population
    • Age Distribution
    • Macroeconomic Environment
      • Global Economic Outlook
      • Per Capita Gross Domestic Product
    • Global Healthcare Trends
      • Infectious Disease Cases
      • Medical Providers
      • Patient Activity
  • Chapter 3: Infectious Disease IVD Products & Markets
    • Overview
    • Healthcare-Associated Infections (HAIs)
      • Clostridium difficile (C. diff)
      • Sepsis
      • Methicillin-Resistant Staphylococcus Aureus (MRSA)
      • Vancomycin-Resistant Enterococcus (VRE)
      • Other HAIs
    • COVID-19
    • Hepatitis IVD Products
    • Sexually Transmitted Infections (STIs)
      • Human Papillomavirus (HPV)
      • Chlamydia Trachomatis (Chlamydia)
      • Gonorrhea
      • Herpes Simplex Virus 2 (HSV-2)
      • Syphilis
      • Other Sexually Transmitted Disease (STD) IVD Products
    • Influenza
    • HIV/AIDS IVD Products
    • Tuberculosis (TB)
    • TORCH
    • All Other Infectious Disease IVD Products
      • Malaria
      • Emerging Infections
      • Chikungunya
      • Fungal Infections
      • Other Parasitic Conditions
      • Lyme Disease
      • Respiratory Syncytial Virus (RSV)
      • Streptococcal Infections
      • Dengue Fever
      • All Other Products
    • Global Infectious Disease IVD Technologies
      • Immunoassays
      • Molecular Technologies
      • Microbiological Testing
      • Pathogen ID/AST Techniques
      • Automated ID/AST Products
      • Manual Panels & Reagents
      • Producers
    • Global Infectious Disease IVD Demand by Market
  • Chapter 4: Global Markets
    • Overview
    • North America
      • United States
      • Canada
      • Mexico
    • Western Europe
      • Germany
      • France
      • United Kingdom
      • Italy
      • Spain
      • Other Western Europe
    • Asia/Pacific
      • China
      • Japan
      • India
      • South Korea
      • Other Asia/Pacific
    • Other Regions
      • Africa/Middle East
      • Central & South America
      • Eastern Europe
  • Chapter 5: Company Profiles
    • Abbott Laboratories
      • Infectious Diseases – Molecular
      • COVID-19
      • HIV Point of Care
      • Blood Bank
    • Becton Dickinson and Company
      • Molecular Microbiology
      • Traditional Microbiology - ID/AST
      • Blood Culture
      • Hospital Acquired Infections
      • Molecular Microbiology
      • Traditional Microbiology - ID/AST
      • Blood Culture
      • Mass Spectrometry
    • Bio-Rad Laboratories
      • Immunoassays
    • bioMérieux
      • Traditional Microbiology
      • Blood Culture
      • Immunoassays
      • BIOFIRE Diagnostics Business
      • Mass Spectrometry
    • Bruker Corporation
    • Danaher Corporation
      • Tuberculosis
      • Microbiology
      • POC Testing Developments
    • DiaSorin
      • Recent Deals and Announcements
    • Grifols S.A.
      • Blood Transfusion Business
    • Hologic
      • PANTHER Molecular System
      • HIV Testing
      • Sexually Transmitted Infections
      • Infectious Diseases
    • QIAGEN
      • Tuberculosis
      • Molecular Expansion
    • QuidelOrtho Corporation
      • Solana Business
      • Molecular – Savanna
      • COVID-19
    • Roche Holding
      • Immunoassays
      • COVID-19
      • Blood Screening
      • HPV
      • Other Recent Developments
    • Siemens Healthineers
    • Thermo Fisher Scientific
      • Microbiology
      • Molecular Test Business
      • COVID-19
Attachments
  • Infectious Disease - 24-024.pdf